other · Healthcare · Biotechnology
IONS
54.99-0.08 -0.15%Past year
Loading chart…
Loading financials…
Company snapshot
- Ticker
- IONS
- Exchange
- NMS
- Sector
- Healthcare
- Industry
- Biotechnology
- Market cap
- $9B
- Employees
- 1,480
- Currency
- USD
- Website
- https://www.ionis.com
Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States. The company offers TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS) and acute pancreatitis; DAWNZERA for prophylaxis to prevent attacks of hereditary angioedema in adults; WAINUA for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults; and SPINRAZA for pediatric…
Latest coverage
No coverage yet — articles appear here automatically as press releases are published.
Related other stocks
Quotes & data
Follow Ionis Pharmaceuticals, Inc. (IONS) across major market-data sources.